Meet the Systane® Family - Designed for All Dry Eye Needs
Explore the Systane® family of products with specially designed formulations for all types of patients’ Dry Eye needs. Find the Systane® solution that is right for your patient.
About Our Vision Care Portfolio
Being a truly global company, Alcon works in over 50 countries and serve patients in more than 140 countries. We are one of the largest manufacturers of contact lenses and lens care products. Our Vision Care portfolio offers a broad range of daily disposable, reusable and color-enhancing contact lenses and a comprehensive portfolio of contact lens solutions.
Product availability varies by market and you can use the filter below to see which products are available country by country. In addition, healthcare professionals and patients can visit the MyAlcon websites in their country to see product availability by market and find out more about our contact lenses and eye care products.
Select Your Country To See The Products
References:
1. REF-00566 - Rangarajan R, Kraybill B, Ogundele A, Ketelson HA. Effects of a hyaluronic acid/hydroxypropyl guar artificial tear solution on protection, recovery, and lubricity in models of corneal epithelium. J Ocul Pharmacol Ther. 2015;31(8):491- 497. doi:10.1089/jop.2014.0164
2. REF-09704 - Rolando M, Autori S, Badino F, Barabino S. Protecting the ocular surface and improving the quality of life of dry eye patients: a study of the efficacy of an HP-Guar containing ocular lubricant in a population of dry eye patients. J Ocul Pharmacol Ther. 2009;25(3):271-278. doi:10.1089/jop.2008.0026
3. REF-18786 - Martin E, Oliver KM, Pearce EI, Tomlinson A, Simmons P, Hagan S. Effect of tear supplements on signs, symptoms and inflammatory markers in dry eye. Cytokine. 2018;105:37-44. doi:10.1016/j.cyto.2018.02.009
4. REF-04850 - Benelli U. Systane lubricant eye drops in the management of ocular dryness. Clin Ophthalmol. 2011;5:783-790. doi:10.2147/OPTH.S13773
5. REF-10317 - Yeu E, Silverstein S, Guillon M, et al. Efficacy and safety of phospholipid nanoemulsion-based ocular lubricant for the management of various subtypes of dry eye disease: A Phase IV, Multicenter Trial. Clin Ophthalmol. 2020;14:2561-2570. doi:10.2147/OPTH.S261318
6. REF-10339 - Silverstein S, Yeu E, Tauber J, et al. Symptom relief following a single dose of propylene glycol-hydroxypropyl guar nanoemulsion in patients with dry eye disease: A Phase IV, Multicenter Trial. Clin Ophthalmol. 2020;14:3167-3177. doi:10.2147/OPTH.S263362
See instructions for use, precautions, warnings and contraindications
